Search results for: 'screening and education'

This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...

Clinical diagnostics is undergoing a radical shift, driven by omics integration for precision health, digital diagnostics services, and smart screening solutions. Digital diagnostics are streamlining data analysis and communication, and enhancing overall efficiency. Smart screening, powered by AI and machine learning, is ensuring early and accurate...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

The current practice of medical education and methods of performing surgery and therapy suffer from limitations such as scarcity of subjects to practice on, suboptimal surgical precision, and therapy-related issues including medication misuse and ineffectiveness of the drugs to treat the conditions. Moreover, the outbreak of COVID-19 pandemic has ...

The International Air Transport Association (IATA) has forecast passenger traffic to nearly double from 3.8 billion in 2015 to 7.2 billion by 2030. This increase will reflect in the number of checked baggage each year with forecasts pegging the number at close to 6.5 billion bags by 2030. As airport operators revise their plans and strategies to ha...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

09 Sep 2025  |  Global  |  Technology Research

Mixed Reality in Healthcare, Global, 2025–2029

Mixed Reality in Healthcare Is Driving Transformational Growth Through Medical Education, Emerging Growth Opportunities, Global Ecosystems, and Advanced Technology Analysis

Infographics

×

Mixed reality (MR) merges real and virtual elements to create interactive environments. Workforce shortages, rising training needs, patient engagement gaps, and the shift toward decentralized care are driving demand for immersive technologies in healthcare. By blending virtual and augmented reality, MR enables learners to practice complex clinical ...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

19 Jan 2024  |  Europe  |  Market Research

European Non-invasive Prenatal Testing Market, Forecast to 2028

Driving Progress in Screening Techniques Amplifies Accessibility and Adoption of NIPT, Cultivating a Broader Patient Engagement in Europe

Infographics

×

The European non-invasive prenatal testing (NIPT) market will experience significant growth thanks to technological advancement, increasing awareness among expectant parents, and the rising incidence of chromosomal abnormalities in fetuses. The market has experienced a surge in demand due to its products non-invasive nature compared to traditional...